BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly regulated space and kept the team motivated while cutting through all the red tape.
FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder
Related Posts
Final 3 days to save up to $500 on your TechCrunch Disrupt 2026 pass
Save up to $500 on your TechCrunch Disrupt 2026 pass until April 10, 11:59 p.m. PT. Secure your spot at…
Lovable reportedly in talks to double its valuation to $13.2B
The $300 million round is expected to be led by Menlo Ventures, Sifted reported.
YouTube expands AI deepfake detection for politicians, government officials, and journalists
YouTube’s AI deepfake detection tool is becoming available to politicians, journalists, and officials, letting them flag unauthorized likenesses…